420 Magazine Background

The Use Of A Synthetic Cannabinoid In The Management Of Treatment-Resistant Nightmare

Truth Seeker

New Member
Abstract
This is the report of an open label clinical trial to evaluate the effects of nabilone, an endocannabinoid receptor agonist, on treatment-resistant nightmares in patients diagnosed with posttraumatic stress disorder (PTSD). METHODS: Charts of 47 patients diagnosed with PTSD and having continuing nightmares in spite of conventional antidepressants and hypnotics were reviewed after adjunctive treatment with nabilone was initiated. These patients had been referred to a psychiatric specialist outpatient clinic between 2004 and 2006. The majority of patients (72%) receiving nabilone experienced either cessation of nightmares or a significant reduction in nightmare intensity. Subjective improvement in sleep time, the quality of sleep, and the reduction of daytime flashbacks and nightsweats were also noted by some patients. The results of this study indicate the potential benefits of nabilone, a synthetic cannabinoid, in patients with PTSD experiencing poor control of nightmares with standard pharmacotherapy. This is the first report of the use of nabilone (Cesamet; Valeant Canada, Ltd., Montreal, Canada) for the management of treatment-resistant nightmares in PTSD.

Source: The use of a synthetic cannabinoid in the ... [CNS Neurosci Ther. 2009] - PubMed - NCBI
 

strfiter

New Member
Re: The Use Of A Synthetic Cannabinoid In The Management Of Treatment-Resistant Night

What about nabilone's effect on the brain over time compared to other synthetic cannabinoids
 

Fooken Eh

New Member
Re: The Use Of A Synthetic Cannabinoid In The Management Of Treatment-Resistant Night

What about nabilone's effect on the brain over time compared to other synthetic cannabinoids
That's what I'm looking at as I've been on it for 2 years(for ptsd) but am considering making the switch as it does leave a chemical hangover in the morning...
 
Top Bottom